VVOS
Vivos Therapeutics, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$0.16
−7.27%Next report
Analyst consensus
- Next report date
- Nov 18, 2026
- EPS estimate
- -$0.28
- Revenue estimate
- $6.3M
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$0.31
- EPS estimate
- -$0.41
- Revenue actual
- $5.2M
- Revenue estimate
- $5.6M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -21.8%
- Revenue beats (12Q)
- 3
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 14, 2026 | -$0.41 | -$0.31 | Beat 24.39% | $5.2M |
| May 20, 2026 | -$0.45 | -$0.52 | Miss -15.56% | $5.1M |
| Nov 19, 2025 | -$0.53 | -$0.49 | Beat 7.55% | $6.8M |
| Aug 19, 2025 | -$0.27 | -$0.55 | Miss -103.70% | $3.8M |
| May 15, 2025 | -$0.44 | -$0.45 | Miss -2.27% | $3.0M |
| Mar 31, 2025 | -$0.43 | -$0.28 | Beat 34.88% | $3.7M |
| Nov 14, 2024 | -$0.70 | -$0.40 | Beat 42.86% | $3.9M |
| Aug 14, 2024 | -$1.05 | -$0.60 | Beat 42.86% | $4.1M |
| May 14, 2024 | -$1.17 | -$1.63 | Miss -39.32% | $3.4M |
| Nov 14, 2023 | -$3.12 | -$1.75 | Beat 43.91% | $3.3M |
| Aug 16, 2023 | -$3.75 | -$3.75 | In line | $3.4M |
| Jun 8, 2023 | -$4.25 | -$5.00 | Miss -17.65% | $3.9M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 18, 2026